GERARD J MICHEL
CIK 1235644 · CHIEF EXECUTIVE OFFICER · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.01M
Companies
7
Total Filings
68
Lifetime Open-Market Net
-$1.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBNX | Director | 33,509 | $14.53 | $486.9K | $0 | 3 | 2026-05-26 |
| DCTH | CHIEF EXECUTIVE OFFICER | 342,034 | $11.72 | $4.01M | $1.47M | 23 | 2026-03-03 |
| VCEL | CFO and VP, Corp. Development | 253,865 | $37.46 | $9.51M | -$2.86M | 23 | 2020-04-03 |
| Vericel Corp (ASTM) Delisted | CFO and VP, Corp. Development | 20,000 | — | — | $51.0K | 1 | 2014-09-17 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | CFO, VP of Corp and Dev/Treas | 45,670 | — | — | -$8.2K | 13 | 2014-03-14 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | CFO & VP, Corp. Development | — | — | — | $0 | 4 | 2007-10-16 |
| EP MEDSYSTEMS INC (EPMD) Delisted | Director | — | — | — | $0 | 1 | 2007-01-11 |
Recent Filings · Page 6 of 7
68 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Mixed | +3,853 | $0 | EDGAR |
| 2013-12-23 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Mixed | +3,829 | $0 | EDGAR |
| 2012-12-21 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-02 | ALBIREO PHARMA, INC. (BIOD) Delisted | Mixed | +16,759 | -$35.0K | EDGAR |
| 2012-04-02 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Exer (M) | +34,100 | $0 | EDGAR |
| 2011-11-29 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-10 | ALBIREO PHARMA, INC. (BIOD) Delisted | Mixed | +7,600 | -$8.2K | EDGAR |
| 2010-12-16 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.